Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37076 - 37100 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	EPHA3	2042	downregulated	entinostat results in decreased expression of EPHA3 mRNA	3p11.1	A21035
Entinostat	Investigational	EPHA4	2043	downregulated	entinostat results in decreased expression of EPHA4 mRNA	2q36.1	A21037 A21035
Entinostat	Investigational	EPHA7	2045	upregulated	entinostat results in increased expression of EPHA7 mRNA	6q16.1	A21037
Entinostat	Investigational	EPHA8	2046	upregulated	entinostat results in increased expression of EPHA8 mRNA	1p36.12	A21037
Entinostat	Investigational	EPHX3	79852	upregulated	entinostat results in increased expression of EPHX3 mRNA	19p13.12	A21037 A21035
Entinostat	Investigational	EPOR	2057	upregulated	entinostat results in increased expression of EPOR mRNA	19p13.2	A21037 A21035
Entinostat	Investigational	EPS8L2	64787	upregulated	entinostat results in increased expression of EPS8L2 mRNA	11p15.5	A21037
Entinostat	Investigational	EPYC	1833	upregulated	entinostat results in increased expression of EPYC mRNA	12q21.33	A21035
Entinostat	Investigational	ERAP1	51752	downregulated	entinostat results in decreased expression of ERAP1 mRNA	5q15	A21037
Entinostat	Investigational	ERAP1	51752	upregulated	entinostat results in increased expression of ERAP1 mRNA	5q15	A21035
Entinostat	Investigational	ERBB3	2065	upregulated	entinostat results in increased expression of ERBB3 mRNA	12q13.2	A21037
Entinostat	Investigational	ERC1	23085	upregulated	entinostat results in increased expression of ERC1 mRNA	12p13.33	A21035
Entinostat	Investigational	ERFE	151176	upregulated	entinostat results in increased expression of ERFE mRNA	2q37.3	A21037
Entinostat	Investigational	ERICH1	157697	upregulated	entinostat results in increased expression of ERICH1 mRNA	8p23.3	A21035
Entinostat	Investigational	ERP27	121506	downregulated	entinostat results in decreased expression of ERP27 mRNA	12p12.3	A21037
Entinostat	Investigational	ERP44	23071	downregulated	entinostat results in decreased expression of ERP44 mRNA	9q31.1	A21037
Entinostat	Investigational	ERVH-1	100616446	upregulated	entinostat results in increased expression of ERVH-1 mRNA	4p15.2	A21037
Entinostat	Investigational	ERVH-4	51359	upregulated	entinostat results in increased expression of ERVH-4 mRNA	14q32.2	A21037
Entinostat	Investigational	ERVH48-1	90625	upregulated	entinostat results in increased expression of ERVH48-1 mRNA	21q22.3	A21037 A21035
Entinostat	Investigational	ERVH-6	51581	upregulated	entinostat results in increased expression of ERVH-6 mRNA	Yq11.223	A21037
Entinostat	Investigational	ERVMER61-1	339476	upregulated	entinostat results in increased expression of ERVMER61-1 mRNA	1q31.1	A21037 A21035
Entinostat	Investigational	ERVW-1	30816	upregulated	entinostat results in increased expression of ERVW-1 mRNA	7q21.2	A21035
Entinostat	Investigational	ESRG	790952	downregulated	entinostat results in decreased expression of ESRG mRNA	3p14.3	A21035
Entinostat	Investigational	ESRG	790952	upregulated	entinostat results in increased expression of ESRG mRNA	3p14.3	A21037
Entinostat	Investigational	ESRP1	54845	upregulated	entinostat results in increased expression of ESRP1 mRNA	8q22.1	A21037

Displaying entries 37076 - 37100 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability